AzTrials
AzTrials

General Anaesthesia During PregnancyPAE-IQNCT06633406

Intelligence and Neurodevelopmental Disorders After Prenatal Exposure to General Anaesthesia

An observational study of General Anaesthesia During Pregnancy, run by Universitaire Ziekenhuizen KU Leuven at 3 sites in Belgium.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record

Search all trials

Trial summary

Every year in the European Union, thousands of babies are exposed to anaesthesia before they are born because their mothers need surgery during pregnancy. While these surgeries are necessary, there is a concern that the anaesthesia might affect the baby's brain development. Read more about this study

Who is it for?
Ages 6 to 27 yearsHealthy volunteers can take part
Conditions the study is for
General Anaesthesia During Pregnancy
What is being tested?
Age-appropriate Wechsler Intelligence Test, Disruptive Behavior Disorders Rating Scale and Social Responsiveness Scale
Type of treatment
Injection or infusion
How many people
192 participants
Where
3 sitesBelgium
Study dates
14 Oct 2024to Dec 2027
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 27 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: children from women who delivered in one of the participating hospitals

Who may be able to join

  • Prenatal anaesthesia exposure: Children exposed in utero to maternal general anaesthesia to allow laparoscopy or laparotomy for appendicectomy, adnexal pathology, cholecystectomy or for diagnostic procedures to rule out intra-abdominal pathology
  • No prenatal anaesthesia exposure: Children not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero
  • Children exposed to inflammation: Children born to mothers diagnosed with inflammatory bowel disease (IBD) who had a flare-up during pregnancy without being exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero.
  • Children born in 2000-2023
  • (Parental) informed consent

Who cannot join

  • Children whose mothers underwent obstetric surgery or foetal surgery/interventions during the same pregnancy.
  • No Dutch-speaking children
  • Diagnosis of severe disability of genetic origin (e.g., Fragil X, Down syndrome,…), history of head trauma, major congenital birth defects

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium3 sites
  • Imeldaziekenhuis

    Bonheiden, Antwerpen, 2820

  • UZ Leuven

    Leuven, Vlaams-Brabant, 3000

  • AZ Delta

    Roeselare, West-Flanders, 8800

Other trials in Belgium

About this study

Official title: Intelligence and Neurodevelopmental Disorders After Prenatal Exposure to General Anaesthesia for Maternal Abdominal Surgery: A Propensity Score Weighted Multicentre Clinical Bidirectional Cohort Study.

Every year in the European Union, thousands of babies are exposed to anaesthesia before they are born because their mothers need surgery during pregnancy. While these surgeries are necessary, there is a concern that the anaesthesia might affect the baby's brain development. However, there isn't enough research to know for sure how this exposure might impact the child's intelligence or behavior later in life.

The goal of this cohort study is to compare the intelligence and neurodevelopmental outcome of children prenatally exposed to general anaesthesia for maternal abdominal surgery with those of unexposed children and with those of children prenatally exposed to maternal inflammation.

Being tested
Age-appropriate Wechsler Intelligence Test, Disruptive Behavior Disorders Rating Scale, Social Responsiveness Scale
Keywords
anaesthesia, anaesthesia-induced neurotoxicity, pregnancy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Age-appropriate Wechsler Intelligence TestOther

    6-16 years: Wechsler Intelligence Scale for Children (WISC V)

    >17 years: Wechsler Adult Intelligence Scale (WAIS IV)

  • Disruptive Behavior Disorders Rating ScaleOther

    Dutch version of the Disruptive Behavior Disorders Rating Scale

  • Social Responsiveness ScaleOther

    6-18 years: social responsiveness scale 2 (SRS-2)

    >19 years: Social Responsiveness Scale - Adult version (SRS-A)

Study groups in NCT06633406
Study groupRoleWhat they receive
Prenatal Anaesthesia ExposureChildren exposed in utero to maternal general anaesthesia to allow laparoscopy or laparotomy for appendicectomy, adnexal pathology, cholecystectomy or for diagnostic procedures to rule out intra-abdominal pathology
Receives: Other: Age-appropriate Wechsler Intelligence Test; Other: Disruptive Behavior Disorders Rating Scale; Other: Social Responsiveness Scale
No Prenatal Anaesthesia ExposureChildren not exposed to general anaesthesia for non-obstetric or obstetric (e.g. cesarean section) surgery in utero
Receives: Other: Age-appropriate Wechsler Intelligence Test; Other: Disruptive Behavior Disorders Rating Scale; Other: Social Responsiveness Scale
Prenatal exposure to maternal inflammationChildren prenatally exposed to maternal inflammation, specifically those born to mothers with inflammatory bowel disease (IBD)
Receives: Other: Age-appropriate Wechsler Intelligence Test; Other: Disruptive Behavior Disorders Rating Scale; Other: Social Responsiveness Scale

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wechsler full-scale intelligence quotient

    Primary outcome will be the Wechsler full-scale intelligence quotient which will be assessed using the Wechsler Intelligence Scale for Children for children with an age of 7-16 years and the Wechsler Adult Intelligence Scale for children with an age of ≥ 17 years.

    Measured: 1,5 hours (duration of intelligence testing and completion of questionnaires)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2024
  2. Study start14 Oct 2024
  3. Primary completionOct 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
192 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06633406
Sponsor's protocol ID
S68647
Acronym
PAE-IQ
Status last verified
Jan 2026
First submitted
20 Sep 2024
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in